Literature DB >> 7964460

T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand.

P Life1, J F Gauchat, V Schnuriger, S Estoppey, G Mazzei, A Durandy, A Fischer, J Y Bonnefoy.   

Abstract

The induction of immunoglobulin E (IgE) switching in B cells requires at least two signals. The first is given by either of the soluble lymphokines interleukin 4 (IL-4) or IL-13, whereas the second is contact dependent. It has been widely reported that a second signal can be provided by the CD40 ligand (CD40L) expressed on the surface of T cells, mast cells, and basophils. A defect in the CD40L has been shown recently to be responsible for the lack of IgE, IgA, and IgG, characteristic of the childhood X-linked immunodeficiency, hyper IgM syndrome (HIGM1). IgE can however be detected in the serum of some HIGM1 patients. In this study, we isolated T cell clones and lines using phytohemagglutinin (PHA) and allergen, respectively, from the peripheral blood of one such patient who expressed a truncated form of CD40L, and investigated their ability to induce IgE switching in highly purified, normal tonsillar B cells in vitro. Unexpectedly, 4 of 12 PHA clones tested induced contact-dependent IgE synthesis in the presence of exogenous IL-4. These clones were also shown to strongly upregulated IL-4-induced germline epsilon RNA and formed dense aggregates with B cells. Of the four helper clones, three were CD8+, of which two were characteristic of the T helper cell 2 (Th2) subtype. Two allergen-specific HIGM1 T cell lines, both of the Th0 subtype, could also drive IgE synthesis when prestimulated using specific allergen. All clones and lines were negative for surface expression of CD40L, and the mutated form of CD40L was confirmed for a representative clone by RNase protection assay and sequencing. The IgE helper activity could not be attributed to membrane tumor necrosis factor alpha (TNF-alpha) although it was strongly expressed on activated clones, and the addition of neutralizing anti-TNF-alpha antibody did not abrogate IgE synthesis. These results therefore suggest the involvement of T cell surface molecules other than CD40L in the induction of IgE synthesis, and that these molecules may also be implicated in other aspects of T-B cell interactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964460      PMCID: PMC2191738          DOI: 10.1084/jem.180.5.1775

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Mitogen- and IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed heavy chain class switching.

Authors:  S Lutzker; P Rothman; R Pollock; R Coffman; F W Alt
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

2.  Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc epsilon RII monoclonal antibodies.

Authors:  J Y Bonnefoy; J Shields; J J Mermod
Journal:  Eur J Immunol       Date:  1990-01       Impact factor: 5.532

3.  Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.

Authors:  C B Thompson; I Scher; M E Schaefer; T Lindsten; F D Finkelman; J J Mond
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

4.  Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.

Authors:  T A Fong; T R Mosmann
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

5.  IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.

Authors:  G Thyphronitis; G C Tsokos; C H June; A D Levine; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; X Paliard; J Banchereau; H Spits; J E De Vries
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.

Authors:  S Lederman; M J Yellin; A M Cleary; A Pernis; G Inghirami; L E Cohn; L R Covey; J J Lee; P Rothman; L Chess
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

9.  Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.

Authors:  D A Lebman; R L Coffman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

10.  Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens.

Authors:  D Vercelli; H H Jabara; K Arai; R S Geha
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  5 in total

1.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.

Authors:  Mikhail B Litinskiy; Bernardetta Nardelli; David M Hilbert; Bing He; Andras Schaffer; Paolo Casali; Andrea Cerutti
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

Review 2.  CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.

Authors:  A Bhushan; L R Covey
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Characterization of E-selectin-binding epitopes expressed by skin-homing T cells.

Authors:  R Priest; M I Bird; R Malhotra
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

4.  Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes.

Authors:  J Punnonen; B G Cocks; J M Carballido; B Bennett; D Peterson; G Aversa; J E de Vries
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

5.  CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.

Authors:  P Borrow; A Tishon; S Lee; J Xu; I S Grewal; M B Oldstone; R A Flavell
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.